🇮🇹 Xmab5574 in Italy

Xmab5574 (tafasitamab) regulatory status in Italy.

Marketing authorisation

AIFA

  • Local brand name: Minjuvi
  • Status: approved

Xmab5574 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Italy

Frequently asked questions

Is Xmab5574 approved in Italy?

Yes. AIFA has authorised it.

Who is the marketing authorisation holder for Xmab5574 in Italy?

Morphosys Us Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.